China AI Biotech Firm Raises $200 Million in Oman-Backed Round

Bloomberg
Read full story
MegaRobo Technologies, a Chinese biotech startup, secured nearly $200 million in funding from investors including Oman's sovereign wealth fund, reflecting growing investment in AI and robotics for drug research acceleration.


More in Healthcare